<code id='C22A281CFC'></code><style id='C22A281CFC'></style>
      • <acronym id='C22A281CFC'></acronym>
      <center id='C22A281CFC'><center id='C22A281CFC'><tfoot id='C22A281CFC'></tfoot></center><abbr id='C22A281CFC'><dir id='C22A281CFC'><tfoot id='C22A281CFC'></tfoot><noframes id='C22A281CFC'>
      • <optgroup id='C22A281CFC'><strike id='C22A281CFC'><sup id='C22A281CFC'></sup></strike><code id='C22A281CFC'></code></optgroup>
        5. <b id='C22A281CFC'><label id='C22A281CFC'><select id='C22A281CFC'><dt id='C22A281CFC'><span id='C22A281CFC'></span></dt></select></label></b><u id='C22A281CFC'></u>
          <i id='C22A281CFC'><strike id='C22A281CFC'><tt id='C22A281CFC'><pre id='C22A281CFC'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / fashion / leisure time      
           
     
           
      
          leisure time 
           
      
           
      
           
       2025-09-06 07:25:39 
   
      
           
      
           
                        
          leisure time  
          
                                   
                 
                                      author：knowledge   
                                        
                                      
                                      Page View：13
                                  
                                    
          
                                   
          Franklin faces
          Adobe
          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.
          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.
          advertisement
          Arch declined to comment on the new fundraising.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Startup Neumora takes a novel depression drug to Phase 3
                                
                            
          Next article：  
                                      
                                          United colonoscopy coverage change 'may cost lives,' doctors say
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles